{"DataElement":{"publicId":"2646435","version":"1","preferredName":"Kaposi Sarcoma Number Malignant Neoplasm Cutaneous Assessment Status","preferredDefinition":"the status of the number of cutaneous (skin) malignant neoplasms of Kaposi Sarcoma.","longName":"KS_N_MN_C_ASESS_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2640354","version":"1","preferredName":"Kaposi Sarcoma Number Malignant Neoplasm Cutaneous Assessment","preferredDefinition":"information relating to an assessment of the number of cutaneous (skin) malignant neoplasms of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells).","longName":"KS_N_MN_CUT_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2640350","version":"1","preferredName":"Kaposi Sarcoma Number Malignant Neoplasm","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9087:C25337:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FDB3D1-CC7A-2689-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2646195","version":"1","preferredName":"Cutaneous Assessment","preferredDefinition":"(kyoo-TAY-nee-us) Having to do with the skin.:The final result of a determination of the value, significance, or extent of.","longName":"C13316:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous","conceptCode":"C13316","definition":"Involving the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31D6E6C7-F1F1-0CAB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-01","modifiedBy":"ONEDATA","dateModified":"2007-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FDBF93-9C94-27BD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2646434","version":"1","preferredName":"Kaposi Sarcoma Number Malignant Neoplasm Cutaneous Assessment Status","preferredDefinition":"the status of the number of cutaneous (skin) malignant neoplasms of Kaposi Sarcoma.","longName":"KS_N_MN_C_ASESS_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete resolution","valueDescription":"Complete resolution","ValueMeaning":{"publicId":"2646436","version":"1","preferredName":"Complete resolution","longName":"2646436","preferredDefinition":"Complete resolution","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDE3A3-B4FC-0C65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EDE9EA-639A-0D41-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":">=50% decrease in the number of lesions since baseline","valueDescription":">=50% decrease in the number of lesions since baseline","ValueMeaning":{"publicId":"2646437","version":"1","preferredName":">=50% decrease in the number of lesions since baseline","longName":"2646437","preferredDefinition":">=50% decrease in the number of lesions since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDDD1D-871F-0B30-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EDE9EA-63AC-0D41-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":">=25% increase in the number of lesions since baseline or since best response","valueDescription":">=25% increase in the number of lesions since baseline or since best response","ValueMeaning":{"publicId":"2646438","version":"1","preferredName":">=25% increase in the number of lesions since baseline or since best response","longName":"2646438","preferredDefinition":">=25% increase in the number of lesions since baseline or since best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDE838-9C55-0B36-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EDE9EA-63BE-0D41-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None of the above","ValueMeaning":{"publicId":"2577583","version":"1","preferredName":"None of the above","longName":"2577583v1.00","preferredDefinition":"None of the choices above are suitable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None of the Above","conceptCode":"C133298","definition":"None of the choices above are suitable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC1C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EDE9EA-63CA-0D41-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":"Greater than or equal to 50%  decrease in number of lesions since baseline","valueDescription":"Greater than or equal to 50%  decrease in number of lesions since baseline","ValueMeaning":{"publicId":"5838510","version":"1","preferredName":"Greater than or equal to 50%  decrease in number of lesions since baseline","longName":"5838510","preferredDefinition":"Greater than or equal to 50%  decrease in number of lesions since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506DE088-2179-296B-E053-F662850ADB11","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SOKKERL","dateModified":"2017-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5071443F-93EE-266A-E053-F662850AAFA2","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"Greater than or equal to 25% increase in the number of lesions since baseline","valueDescription":"Greater than or equal to 25% increase in the number of lesions since baseline","ValueMeaning":{"publicId":"5839435","version":"1","preferredName":"Greater than or equal to 25% increase in the number of lesions since baseline","longName":"5839435","preferredDefinition":"Greater than or equal to 25% increase in the number of lesions since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50BEF0D4-3E0F-4EB0-E053-F662850A9F8D","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"50BEF0D4-3E28-4EB0-E053-F662850A9F8D","beginDate":"2017-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-30","modifiedBy":"ONEDATA","dateModified":"2017-05-30","deletedIndicator":"No"},{"value":"5 or more new lesions in area(s) with no previous cutaneous disease if participant had greater than 50 lesions at baseline","valueDescription":"5 or more new lesions in area(s) with no previous cutaneous disease if participant had greater than 50 lesions at baseline","ValueMeaning":{"publicId":"7372079","version":"1","preferredName":"5 or more new lesions in area(s) with no previous cutaneous disease if participant had greater than 50 lesions at baseline","longName":"7372079","preferredDefinition":"5 or more new lesions in area(s) with no previous cutaneous disease if participant had greater than 50 lesions at baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81EAF8-2415-2AB1-E053-4EBD850A8DE1","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81EAF8-242E-2AB1-E053-4EBD850A8DE1","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=25% increase in the number of lesions or a minimum of 5 new lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","valueDescription":">=25% increase in the number of lesions or a minimum of 5 new lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","ValueMeaning":{"publicId":"7372080","version":"1","preferredName":">=25% increase in the number of lesions or a minimum of 5 new lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","longName":"7372080","preferredDefinition":">=25% increase in the number of lesions or a minimum of 5 new lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81EAF8-2438-2AB1-E053-4EBD850A8DE1","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81EAF8-2451-2AB1-E053-4EBD850A8DE1","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"<25% increase in the number of lesions compared to baseline or best response","valueDescription":"<25% increase in the number of lesions compared to baseline or best response","ValueMeaning":{"publicId":"7372081","version":"1","preferredName":"<25% increase in the number of lesions compared to baseline or best response","longName":"7372081","preferredDefinition":"<25% increase in the number of lesions compared to baseline or best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81EAF8-245B-2AB1-E053-4EBD850A8DE1","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81EAF8-2474-2AB1-E053-4EBD850A8DE1","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"<50% decrease in the number of lesions present","valueDescription":"<50% decrease in the number of lesions present","ValueMeaning":{"publicId":"7372082","version":"1","preferredName":"<50% decrease in the number of lesions present","longName":"7372082","preferredDefinition":"<50% decrease in the number of lesions present","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81EAF8-247E-2AB1-E053-4EBD850A8DE1","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81EAF8-2497-2AB1-E053-4EBD850A8DE1","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=50% decrease in the number of lesions","valueDescription":">=50% decrease in the number of lesions","ValueMeaning":{"publicId":"7372083","version":"1","preferredName":">=50% decrease in the number of lesions","longName":"7372083","preferredDefinition":">=50% decrease in the number of lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81EAF8-24A1-2AB1-E053-4EBD850A8DE1","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81EAF8-24BA-2AB1-E053-4EBD850A8DE1","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"Complete resolution of any detectable residual disease","valueDescription":"Complete resolution of any detectable residual disease","ValueMeaning":{"publicId":"7372078","version":"1","preferredName":"Complete resolution of any detectable residual disease","longName":"7372078","preferredDefinition":"Complete resolution of any detectable residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-3599-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81EAF8-24C4-2AB1-E053-4EBD850A8DE1","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184340","version":"1","preferredName":"Status","preferredDefinition":"Status; a condition or state at a particular time.","longName":"Status","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20AD-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDDA8D-074A-0C7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"CAMPBELB","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"TRORRES_NCUTLES","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Number of cutaneous lesions","type":"Preferred Question Text","description":"Number of cutaneous lesions","url":null,"context":"CTEP"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Evaluation of cutaneous lesions","url":null,"context":"Theradex"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDDD1D-870C-0B30-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"COLLIED","dateModified":"2020-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}